EP Patent

EP2931899A1 — Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof

Assigned to Massachusetts Institute of Technology · Expires 2015-10-21 · 11y expired

What this patent protects

The present invention generally relates to compositions, methods applications and screens used in functional genomics that focus on gene function in a ceil and that may use vector systems and other aspects related to Clustered Regularly Interspaced Short Palindromic Repeats (CRIS…

USPTO Abstract

The present invention generally relates to compositions, methods applications and screens used in functional genomics that focus on gene function in a ceil and that may use vector systems and other aspects related to Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)- Cas systems and components thereof. Provided are vectors and vector systems, some of which encode one or more components of a CRISPR complex, as well as methods for the design and use of such vectors. Also provided are methods of directing CRISPR complex formation in eukaryotic cells and methods for utilizing the CRJSPR-Cas system.

Drugs covered by this patent

Patent Metadata

Patent number
EP2931899A1
Jurisdiction
EP
Classification
Expires
2015-10-21
Drug substance claim
No
Drug product claim
No
Assignee
Massachusetts Institute of Technology
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.